{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T16:33:14Z","timestamp":1776443594616,"version":"3.51.2"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81900193"],"award-info":[{"award-number":["81900193"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82130004"],"award-info":[{"award-number":["82130004"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2502600"],"award-info":[{"award-number":["2022YFC2502600"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Chang Jiang Scholars Program, Shanghai Clinical Research Center for Cell Therapy","award":["23J41900100"],"award-info":[{"award-number":["23J41900100"]}]},{"name":"Shanghai Municipal Education Commission Gaofeng Clinical Medicine Grant Support","award":["20152206"],"award-info":[{"award-number":["20152206"]}]},{"name":"Clinical Research Plan of Shanghai Hospital Development Center","award":["SHDC2020CR1032B"],"award-info":[{"award-number":["SHDC2020CR1032B"]}]},{"name":"Multicenter Clinical Research Project by Shanghai Jiao Tong University School of Medicine","award":["DLY201601"],"award-info":[{"award-number":["DLY201601"]}]},{"name":"Multicenter Hematology-Oncology Programs Evaluation System"},{"name":"Collaborative Innovation Center of Systems Biomedicine"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genome Med"],"DOI":"10.1186\/s13073-025-01557-y","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T14:15:03Z","timestamp":1761315303000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical characteristics and molecular heterogeneity in Follicular lymphoma with extranodal involvement"],"prefix":"10.1186","volume":"17","author":[{"given":"Rui-Chi","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Lai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian-Huo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian-Yuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si-Yuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng-Peng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Mei","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Li","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"issue":"1","key":"1557_CR1","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13045-021-01139-6","volume":"14","author":"J Zha","year":"2021","unstructured":"Zha J, Fan L, Yi S, Yu H, Zheng Z, Xu W, et al. Clinical features and outcomes of 1845 patients with follicular lymphoma: a real-world multicenter experience in China. J Hematol Oncol. 2021;14(1):131.","journal-title":"J Hematol Oncol"},{"issue":"6","key":"1557_CR2","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1007\/s12094-023-03081-0","volume":"25","author":"Z Lin","year":"2023","unstructured":"Lin Z, Zha J, Yi S, Li Z, Ping L, He X, et al. Clinical characteristics and outcomes of follicular lymphoma patients with extranodal involvement: analysis of a series of 1090 cases in China. Clin Transl Oncol. 2023;25(6):1821\u20139.","journal-title":"Clin Transl Oncol"},{"issue":"1","key":"1557_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13045-020-01018-6","volume":"14","author":"M Lumish","year":"2021","unstructured":"Lumish M, Falchi L, Imber BS, Scordo M, von Keudell G, Joffe E. How we treat mature B-cell neoplasms (indolent B-cell lymphomas). J Hematol Oncol. 2021;14(1):5.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"1557_CR4","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13045-021-01113-2","volume":"14","author":"W Hanel","year":"2021","unstructured":"Hanel W, Epperla N. Evolving therapeutic landscape in follicular lymphoma: a look at emerging and investigational therapies. J Hematol Oncol. 2021;14(1):104.","journal-title":"J Hematol Oncol"},{"key":"1557_CR5","doi-asserted-by":"crossref","unstructured":"International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin\u2019s lymphoma. N Engl J Med. 1993;329(14):987\u201394.","DOI":"10.1056\/NEJM199309303291402"},{"issue":"5","key":"1557_CR6","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1182\/blood-2003-12-4434","volume":"104","author":"P Solal-C\u00e9ligny","year":"2004","unstructured":"Solal-C\u00e9ligny P, Roy P, Colombat P, White J, Armitage JO, Arranz-Saez R, et al. Follicular Lymphoma International Prognostic Index. Blood. 2004;104(5):1258\u201365.","journal-title":"Blood"},{"issue":"27","key":"1557_CR7","doi-asserted-by":"publisher","first-page":"4555","DOI":"10.1200\/JCO.2008.21.3991","volume":"27","author":"M Federico","year":"2009","unstructured":"Federico M, Bellei M, Marcheselli L, Luminari S, Lopez-Guillermo A, Vitolo U, et al. Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project. J Clin Oncol. 2009;27(27):4555\u201362.","journal-title":"J Clin Oncol"},{"issue":"7","key":"1557_CR8","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1182\/blood-2015-10-673236","volume":"127","author":"B Chapuy","year":"2016","unstructured":"Chapuy B, Roemer MG, Stewart C, Tan Y, Abo RP, Zhang L, et al. Targetable genetic features of primary testicular and primary central nervous system lymphomas. Blood. 2016;127(7):869\u201381.","journal-title":"Blood"},{"issue":"2","key":"1557_CR9","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41379-020-00660-2","volume":"34","author":"V Vela","year":"2021","unstructured":"Vela V, Juskevicius D, Prince SS, Cathomas G, Dertinger S, Diebold J, et al. Deciphering the genetic landscape of pulmonary lymphomas. Mod Pathol. 2021;34(2):371\u20139.","journal-title":"Mod Pathol"},{"key":"1557_CR10","doi-asserted-by":"crossref","unstructured":"Sarro R, Bisig B, Guey B, Missiaglia E, Cairoli A, Omoumi P, et al. Follicular Lymphoma Presenting With Symptomatic Bone Involvement: A Clinicopathologic and Molecular Analysis of 16 Cases. Mod Pathol. 2024;37(4):100440.","DOI":"10.1016\/j.modpat.2024.100440"},{"key":"1557_CR11","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.humpath.2023.04.007","volume":"136","author":"H Kim","year":"2023","unstructured":"Kim H, Shin D, Son SM, Cho J, Kim JE, Kim Y, et al. Clinicopathological and molecular genetic characteristics of primary gastric follicular lymphoma. Hum Pathol. 2023;136:114\u201322.","journal-title":"Hum Pathol"},{"issue":"9","key":"1557_CR12","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1093\/jnen\/nlab080","volume":"80","author":"G Karpathiou","year":"2021","unstructured":"Karpathiou G, Ferrand E, Camy F, Babiuc SM, Papoudou-Bai A, Dumollard JM, et al. Expression of STAT6 and phosphorylated STAT6 in primary central nervous system lymphomas. J Neuropathol Exp Neurol. 2021;80(9):830\u20134.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"34","key":"1557_CR13","doi-asserted-by":"publisher","first-page":"3300","DOI":"10.1200\/JCO.18.02365","volume":"37","author":"JWD Tobin","year":"2019","unstructured":"Tobin JWD, Keane C, Gunawardana J, Mollee P, Birch S, Hoang T, et al. Progression of disease within 24 months in follicular lymphoma is associated with reduced intratumoral immune infiltration. J Clin Oncol. 2019;37(34):3300\u20139.","journal-title":"J Clin Oncol"},{"issue":"8","key":"1557_CR14","doi-asserted-by":"publisher","first-page":"e457","DOI":"10.1038\/bcj.2016.67","volume":"6","author":"L He","year":"2016","unstructured":"He L, Zhu HY, Qin SC, Li Y, Miao Y, Liang JH, et al. Low natural killer (NK) cell counts in peripheral blood adversely affect clinical outcome of patients with follicular lymphoma. Blood Cancer J. 2016;6(8):e457.","journal-title":"Blood Cancer J"},{"key":"1557_CR15","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jocn.2024.04.009","volume":"124","author":"H Shi","year":"2024","unstructured":"Shi H, Sun X, Wu Y, Cui Q, Sun S, Ji N, et al. Targeting the tumor microenvironment in primary central nervous system lymphoma: implications for prognosis. J Clin Neurosci. 2024;124:36\u201346.","journal-title":"J Clin Neurosci"},{"issue":"20","key":"1557_CR16","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375\u201390.","journal-title":"Blood"},{"issue":"2","key":"1557_CR17","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1182\/blood.V94.2.429","volume":"94","author":"G Jerusalem","year":"1999","unstructured":"Jerusalem G, Beguin Y, Fassotte MF, Najjar F, Paulus P, Rigo P, et al. Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin\u2019s disease and non-Hodgkin\u2019s lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging. Blood. 1999;94(2):429\u201333.","journal-title":"Blood"},{"issue":"17","key":"1557_CR18","doi-asserted-by":"publisher","first-page":"4166","DOI":"10.1002\/cncr.27381","volume":"118","author":"H Takahashi","year":"2012","unstructured":"Takahashi H, Tomita N, Yokoyama M, Tsunoda S, Yano T, Murayama K, et al. Prognostic impact of extranodal involvement in diffuse large B-cell lymphoma in the rituximab era. Cancer. 2012;118(17):4166\u201372.","journal-title":"Cancer"},{"issue":"2","key":"1557_CR19","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","volume":"31","author":"S Anders","year":"2015","unstructured":"Anders S, Pyl PT, Huber W. HTSeq\u2013a Python framework to work with high-throughput sequencing data. Bioinformatics. 2015;31(2):166\u20139.","journal-title":"Bioinformatics"},{"issue":"7","key":"1557_CR20","doi-asserted-by":"publisher","first-page":"e221","DOI":"10.1002\/ctm2.221","volume":"10","author":"R Shen","year":"2020","unstructured":"Shen R, Xu PP, Wang N, Yi HM, Dong L, Fu D, et al. Influence of oncogenic mutations and tumor microenvironment alterations on extranodal invasion in diffuse large B-cell lymphoma. Clin Transl Med. 2020;10(7):e221.","journal-title":"Clin Transl Med"},{"issue":"43","key":"1557_CR21","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"1557_CR22","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003;34(3):267\u201373.","journal-title":"Nat Genet"},{"issue":"43","key":"1557_CR23","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci. 2005;102(43):15545\u201350.","journal-title":"Proc Natl Acad Sci"},{"issue":"5","key":"1557_CR24","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453\u20137.","journal-title":"Nat Methods"},{"issue":"23","key":"1557_CR25","doi-asserted-by":"publisher","first-page":"6575","DOI":"10.1158\/0008-5472.CAN-18-0689","volume":"78","author":"L Xu","year":"2018","unstructured":"Xu L, Deng C, Pang B, Zhang X, Liu W, Liao G, et al. Tip: a web server for resolving tumor immunophenotype profiling. Cancer Res. 2018;78(23):6575\u201380.","journal-title":"Cancer Res"},{"issue":"6","key":"1557_CR26","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1182\/blood-2017-08-737361","volume":"131","author":"MR Green","year":"2018","unstructured":"Green MR. Chromatin modifying gene mutations in follicular lymphoma. Blood. 2018;131(6):595\u2013604.","journal-title":"Blood"},{"issue":"7","key":"1557_CR27","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nrc3068","volume":"11","author":"BG Wilson","year":"2011","unstructured":"Wilson BG, Roberts CW. Swi\/snf nucleosome remodellers and cancer. Nat Rev Cancer. 2011;11(7):481\u201392.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"1557_CR28","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1038\/s41467-024-47012-1","volume":"15","author":"J Li","year":"2024","unstructured":"Li J, Chin CR, Ying HY, Meydan C, Teater MR, Xia M, et al. Loss of CREBBP and KMT2D cooperate to accelerate lymphomagenesis and shape the lymphoma immune microenvironment. Nat Commun. 2024;15(1):2879.","journal-title":"Nat Commun"},{"key":"1557_CR29","doi-asserted-by":"publisher","first-page":"906245","DOI":"10.3389\/fonc.2022.906245","volume":"12","author":"AY Xing","year":"2022","unstructured":"Xing AY, Dong XZ, Zhu LQ, Liu L, Sun D, Guo S. Clinicopathological characteristics and molecular phenotypes of primary hepatic lymphoma. Front Oncol. 2022;12:906245.","journal-title":"Front Oncol"},{"issue":"19","key":"1557_CR30","first-page":"3760","volume":"5","author":"RAL de Groen","year":"2021","unstructured":"de Groen RAL, van Eijk R, B\u00f6hringer S, van Wezel T, Raghoo R, Ruano D, et al. Frequent mutated B2M, EZH2, IRF8, and TNFRSF14 in primary bone diffuse large B-cell lymphoma reflect a GCB phenotype. Blood Adv. 2021;5(19):3760\u201375.","journal-title":"Blood Adv"},{"issue":"9","key":"1557_CR31","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1056\/NEJMoa1200710","volume":"367","author":"SP Treon","year":"2012","unstructured":"Treon SP, Xu L, Yang G, Zhou Y, Liu X, Cao Y, et al. MYD88 L265P somatic mutation in Waldenstr\u00f6m\u2019s macroglobulinemia. N Engl J Med. 2012;367(9):826\u201333.","journal-title":"N Engl J Med"},{"issue":"5","key":"1557_CR32","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/nri1352","volume":"4","author":"M Thome","year":"2004","unstructured":"Thome M. CARMA1, BCL-10 and MALT1 in lymphocyte development and activation. Nat Rev Immunol. 2004;4(5):348\u201359.","journal-title":"Nat Rev Immunol"},{"issue":"5164","key":"1557_CR33","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1126\/science.8197455","volume":"264","author":"JE Darnell Jr","year":"1994","unstructured":"Darnell JE Jr, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science. 1994;264(5164):1415\u201321.","journal-title":"Science"},{"key":"1557_CR34","doi-asserted-by":"publisher","first-page":"622648","DOI":"10.3389\/fonc.2021.622648","volume":"11","author":"P Li","year":"2021","unstructured":"Li P, Chai J, Chen Z, Liu Y, Wei J, Liu Y, et al. Genomic mutation profile of primary gastrointestinal diffuse large B-cell lymphoma. Front Oncol. 2021;11:622648.","journal-title":"Front Oncol"},{"issue":"15","key":"1557_CR35","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1182\/blood.2019004725","volume":"136","author":"AM Gaydosik","year":"2020","unstructured":"Gaydosik AM, Queen DS, Trager MH, Akilov OE, Geskin LJ, Fuschiotti P. Genome-wide transcriptome analysis of the STAT6-regulated genes in advanced-stage cutaneous T-cell lymphoma. Blood. 2020;136(15):1748\u201359.","journal-title":"Blood"},{"issue":"7","key":"1557_CR36","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/j.cell.2005.10.028","volume":"123","author":"Y Fan","year":"2005","unstructured":"Fan Y, Nikitina T, Zhao J, Fleury TJ, Bhattacharyya R, Bouhassira EE, et al. Histone H1 depletion in mammals alters global chromatin structure but causes specific changes in gene regulation. Cell. 2005;123(7):1199\u2013212.","journal-title":"Cell"},{"issue":"7841","key":"1557_CR37","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41586-020-3017-y","volume":"589","author":"N Yusufova","year":"2021","unstructured":"Yusufova N, Kloetgen A, Teater M, Osunsade A, Camarillo JM, Chin CR, et al. Histone H1 loss drives lymphoma by disrupting 3D chromatin architecture. Nature. 2021;589(7841):299\u2013305.","journal-title":"Nature"},{"key":"1557_CR38","doi-asserted-by":"publisher","first-page":"1341745","DOI":"10.3389\/fimmu.2024.1341745","volume":"15","author":"SJ Potter","year":"2024","unstructured":"Potter SJ, Zhang L, Kotliar M, Wu Y, Schafer C, Stefan K, et al. KMT2D regulates activation, localization, and integrin expression by T-cells. Front Immunol. 2024;15:1341745.","journal-title":"Front Immunol"},{"issue":"5","key":"1557_CR39","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.immuni.2024.03.018","volume":"57","author":"S Liu","year":"2024","unstructured":"Liu S, Cao Y, Cui K, Ren G, Zhao T, Wang X, et al. Regulation of t helper cell differentiation by the interplay between histone modification and chromatin interaction. Immunity. 2024;57(5):987-1004.e5.","journal-title":"Immunity"},{"issue":"5","key":"1557_CR40","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.4049\/jimmunol.1900959","volume":"205","author":"A Astori","year":"2020","unstructured":"Astori A, Tingvall-Gustafsson J, Kuruvilla J, Coyaud E, Laurent EMN, Sunnerhagen M, et al. ARID1a associates with lymphoid-restricted transcription factors and has an essential role in T cell development. J Immunol. 2020;205(5):1419\u201332.","journal-title":"J Immunol"},{"issue":"4","key":"1557_CR41","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1084\/jem.20170084","volume":"215","author":"MW Dobenecker","year":"2018","unstructured":"Dobenecker MW, Park JS, Marcello J, McCabe MT, Gregory R, Knight SD, et al. Signaling function of PRC2 is essential for TCR-driven T cell responses. J Exp Med. 2018;215(4):1101\u201313.","journal-title":"J Exp Med"},{"issue":"2 Pt C","key":"1557_CR42","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.molimm.2015.07.024","volume":"68","author":"JH Shi","year":"2015","unstructured":"Shi JH, Sun SC. TCR signaling to NF-\u03baB and mTORC1: expanding roles of the CARMA1 complex. Mol Immunol. 2015;68(2 Pt C):546\u201357.","journal-title":"Mol Immunol"},{"issue":"3","key":"1557_CR43","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.molcel.2013.07.010","volume":"51","author":"MU Kaikkonen","year":"2013","unstructured":"Kaikkonen MU, Spann NJ, Heinz S, Romanoski CE, Allison KA, Stender JD, et al. Remodeling of the enhancer landscape during macrophage activation is coupled to enhancer transcription. Mol Cell. 2013;51(3):310\u201325.","journal-title":"Mol Cell"},{"issue":"52","key":"1557_CR44","doi-asserted-by":"publisher","first-page":"15988","DOI":"10.1073\/pnas.1521740112","volume":"112","author":"J Yin","year":"2015","unstructured":"Yin J, Leavenworth JW, Li Y, Luo Q, Xie H, Liu X, et al. Ezh2 regulates differentiation and function of natural killer cells through histone methyltransferase activity. Proc Natl Acad Sci U S A. 2015;112(52):15988\u201393.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1557_CR45","doi-asserted-by":"crossref","unstructured":"Li L, Li M, Jiang Z, Wang X. ARID1A Mutations Are Associated with Increased Immune Activity in Gastrointestinal Cancer. Cells. 2019;8(7):678.","DOI":"10.3390\/cells8070678"},{"issue":"7","key":"1557_CR46","first-page":"2427","volume":"118","author":"AG Ramsay","year":"2008","unstructured":"Ramsay AG, Johnson AJ, Lee AM, Gorg\u00fcn G, Le Dieu R, Blum W, et al. Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug. J Clin Invest. 2008;118(7):2427\u201337.","journal-title":"J Clin Invest"},{"issue":"11","key":"1557_CR47","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1038\/s41375-018-0114-0","volume":"32","author":"L Busch","year":"2018","unstructured":"Busch L, Mougiakakos D, B\u00fcttner-Herold M, M\u00fcller MJ, Volmer DA, Bach C, et al. Lenalidomide enhances MOR202-dependent macrophage-mediated effector functions via the vitamin D pathway. Leukemia. 2018;32(11):2445\u201358.","journal-title":"Leukemia"},{"issue":"14","key":"1557_CR48","doi-asserted-by":"publisher","first-page":"4650","DOI":"10.1158\/1078-0432.CCR-07-4405","volume":"14","author":"L Wu","year":"2008","unstructured":"Wu L, Adams M, Carter T, Chen R, Muller G, Stirling D, et al. Lenalidomide enhances natural killer cell and monocyte-mediated antibody-dependent cellular cytotoxicity of rituximab-treated CD20+ tumor cells. Clin Cancer Res. 2008;14(14):4650\u20137.","journal-title":"Clin Cancer Res"},{"issue":"10","key":"1557_CR49","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1182\/blood-2018-11-885467","volume":"133","author":"J Merkenschlager","year":"2019","unstructured":"Merkenschlager J, Eksmond U, Danelli L, Attig J, Young GR, Nowosad C, et al. MHC class II cell-autonomously regulates self-renewal and differentiation of normal and malignant B cells. Blood. 2019;133(10):1108\u201318.","journal-title":"Blood"},{"issue":"1","key":"1557_CR50","doi-asserted-by":"publisher","first-page":"6790","DOI":"10.1038\/s41467-024-50830-y","volume":"15","author":"ME Stokes","year":"2024","unstructured":"Stokes ME, Wenzl K, Huang CC, Ortiz M, Hsu CC, Maurer MJ, et al. Transcriptomic classification of diffuse large B-cell lymphoma identifies a high-risk activated B-cell-like subpopulation with targetable MYC dysregulation. Nat Commun. 2024;15(1):6790.","journal-title":"Nat Commun"},{"issue":"6","key":"1557_CR51","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.ccr.2012.05.024","volume":"21","author":"Y Yang","year":"2012","unstructured":"Yang Y, Shaffer AL 3rd, Emre NC, Ceribelli M, Zhang M, Wright G, et al. Exploiting synthetic lethality for the therapy of ABC diffuse large B cell lymphoma. Cancer Cell. 2012;21(6):723\u201337.","journal-title":"Cancer Cell"},{"issue":"4","key":"1557_CR52","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/bjh.12172","volume":"160","author":"LH Zhang","year":"2013","unstructured":"Zhang LH, Kosek J, Wang M, Heise C, Schafer PH, Chopra R. Lenalidomide efficacy in activated B-cell-like subtype diffuse large B-cell lymphoma is dependent upon IRF4 and cereblon expression. Br J Haematol. 2013;160(4):487\u2013502.","journal-title":"Br J Haematol"},{"issue":"1","key":"1557_CR53","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1182\/blood-2017-11-816405","volume":"132","author":"E Bachy","year":"2018","unstructured":"Bachy E, Maurer MJ, Habermann TM, Gelas-Dore B, Maucort-Boulch D, Estell JA, et al. A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy. Blood. 2018;132(1):49\u201358.","journal-title":"Blood"},{"key":"1557_CR54","doi-asserted-by":"crossref","unstructured":"Li R, Tang W, Zhang H, et al. Clinical characteristics and molecular heterogeneity in Follicular Lymphoma with extranodal involvement. HRA013091, Genome Sequence Archive; 2025. Available from: https:\/\/ngdc.cncb.ac.cn\/search\/specific?db=hra&q=HRA013091.","DOI":"10.1186\/s13073-025-01557-y"},{"key":"1557_CR55","unstructured":"Li R, Zheng Z, Zhao W. Source code for RNAseq DEG analysis. 2025. https:\/\/github.com\/RuichiLi\/FL_ENI."}],"container-title":["Genome Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13073-025-01557-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13073-025-01557-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13073-025-01557-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T15:02:53Z","timestamp":1761318173000},"score":1,"resource":{"primary":{"URL":"https:\/\/genomemedicine.biomedcentral.com\/articles\/10.1186\/s13073-025-01557-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1557"],"URL":"https:\/\/doi.org\/10.1186\/s13073-025-01557-y","relation":{},"ISSN":["1756-994X"],"issn-type":[{"value":"1756-994X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"assertion":[{"value":"18 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Shanghai Ruijin Hospital Institutional Review Board and Ethical Committee gave their approval to the study (2018\u2013169). All participants gave written informed consent in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"131"}}